PU-H71

SKU: orb1819131

Description

PU-H71 is an effective selective HSP90 inhibitor with an IC50 of 51 nM.

Research Area

,Metabolism|||Cytoskeletal Signaling

Key Properties

• CAS Number: 873436-91-0
• MW: 512.37
• Purity: 98.31%
• Formula: C₁₈H₂₁IN₆O₂S
• SMILES: CC(C)NCCCn1c(Sc2cc3OCOc3cc2I)nc2c(N)ncnc12

Bioactivity

• Target IC50:
  HSP90:51 nM
• In Vivo:
  MDA-MB-231 model treated with PU-H71 at a dose of 75 mg/kg was 100% fully effective. After 37 days of treatment, tumor was replaced by scar tissue, accompanied by a reduction in many proliferative and anti apoptotic molecules, such as EGFR, HER3, Raf-1, Akt, and p-Akt, which decreased by 80%, 95%, 99%, 80%, and 65%, respectively. PU-H71 (75 mg/kg, three times a week) inhibits tumor growth by 96%, reduces tumor cell proliferation by 60%, decreases activated Akt associated with survival and high invasive potential by 85%, and increases apoptosis by 6-fold.
  Read more...
• In Vitro:
  PU-H71(1 μ M) potently inhibits the growth of triple negative breast cancer (TNBC) cell lines MDA-MB-468, MDA-MB-231, and HCC-1806, with IC50 values of 65, 140, and 87 nM, respectively. PU-H71(1 μ M) kills 80%, 65%, and 80% of MDA-MB-468, MDA-MB-231, and HCC-1806 cells, respectively.
  Read more...

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Compound Identifiers

PubChem CID

9549213